AIMS/HYPOTHESIS: We hypothesised that ectopic fat deposition is present in liver and skeletal muscle before puberty and that both are potentially important factors in the early pathogenesis of insulin resistance. METHODS: Proton magnetic resonance spectroscopy was used to evaluate intramyocellular and intrahepatic lipids in 50 male and 42 female multi-ethnic, prepubertal (Tanner < 2) children (8.1 ± 0.8 years; 35.4 ± 10.7 kg; 27.9 ± 8.3% body fat; means ± SD). Intramyocellular lipid was measured in soleus muscle and intrahepatic lipid in the middle right lobe. Abdominal fat was measured by magnetic resonance imaging, body fat by dual energy X-ray absorptiometry, and insulin resistance using homeostatic model assessment. RESULTS: Intrahepatic lipid ranged from 0.11% to 4.6% relative to the liver water signal (mean 0.79 ± 0.79%) whereas intramyocellular lipid ranged from 0.13% to 1.86% relative to the muscle water signal (mean 0.51 ± 0.28%). Intramyocellular and intrahepatic lipids were significantly correlated with total adiposity (r = 0.49 and 0.59), abdominal adiposity (r = 0.44 and 0.54), and each other (r = 0.39, p < 0.05, Spearman). Both intramyocellular and intrahepatic lipid were positively correlated with fasting insulin (r = 0.37 and 0.38 respectively) and insulin resistance (r = 0.37 and 0.37; p < 0.01). After adjustment for race and sex, the relations between ectopic fat and insulin resistance remained, whereas both disappeared when further adjusted for body fat or BMI z scores. CONCLUSIONS/INTERPRETATIONS: These results suggest that typical relations between body composition, ectopic fat and insulin resistance are present in children before puberty. Thus, interventions aimed at reducing adiposity have the potential to decrease ectopic fat accumulation, delay the onset of insulin resistance and decrease the risk for development of type 2 diabetes in children.
AIMS/HYPOTHESIS: We hypothesised that ectopic fat deposition is present in liver and skeletal muscle before puberty and that both are potentially important factors in the early pathogenesis of insulin resistance. METHODS: Proton magnetic resonance spectroscopy was used to evaluate intramyocellular and intrahepatic lipids in 50 male and 42 female multi-ethnic, prepubertal (Tanner < 2) children (8.1 ± 0.8 years; 35.4 ± 10.7 kg; 27.9 ± 8.3% body fat; means ± SD). Intramyocellular lipid was measured in soleus muscle and intrahepatic lipid in the middle right lobe. Abdominal fat was measured by magnetic resonance imaging, body fat by dual energy X-ray absorptiometry, and insulin resistance using homeostatic model assessment. RESULTS: Intrahepatic lipid ranged from 0.11% to 4.6% relative to the liver water signal (mean 0.79 ± 0.79%) whereas intramyocellular lipid ranged from 0.13% to 1.86% relative to the muscle water signal (mean 0.51 ± 0.28%). Intramyocellular and intrahepatic lipids were significantly correlated with total adiposity (r = 0.49 and 0.59), abdominal adiposity (r = 0.44 and 0.54), and each other (r = 0.39, p < 0.05, Spearman). Both intramyocellular and intrahepatic lipid were positively correlated with fasting insulin (r = 0.37 and 0.38 respectively) and insulin resistance (r = 0.37 and 0.37; p < 0.01). After adjustment for race and sex, the relations between ectopic fat and insulin resistance remained, whereas both disappeared when further adjusted for body fat or BMI z scores. CONCLUSIONS/INTERPRETATIONS: These results suggest that typical relations between body composition, ectopic fat and insulin resistance are present in children before puberty. Thus, interventions aimed at reducing adiposity have the potential to decrease ectopic fat accumulation, delay the onset of insulin resistance and decrease the risk for development of type 2 diabetes in children.
Authors: S Jacob; J Machann; K Rett; K Brechtel; A Volk; W Renn; E Maerker; S Matthaei; F Schick; C D Claussen; H U Häring Journal: Diabetes Date: 1999-05 Impact factor: 9.461
Authors: M Krssak; K Falk Petersen; A Dresner; L DiPietro; S M Vogel; D L Rothman; M Roden; G I Shulman Journal: Diabetologia Date: 1999-01 Impact factor: 10.122
Authors: S R Smith; J C Lovejoy; F Greenway; D Ryan; L deJonge; J de la Bretonne; J Volafova; G A Bray Journal: Metabolism Date: 2001-04 Impact factor: 8.694
Authors: Wayne S Cutfield; Craig A Jefferies; Wendy E Jackson; Elizabeth M Robinson; Paul L Hofman Journal: Pediatr Diabetes Date: 2003-09 Impact factor: 4.866
Authors: G Perseghin; P Scifo; F De Cobelli; E Pagliato; A Battezzati; C Arcelloni; A Vanzulli; G Testolin; G Pozza; A Del Maschio; L Luzi Journal: Diabetes Date: 1999-08 Impact factor: 9.461
Authors: Brian Bennett; D Enette Larson-Meyer; Eric Ravussin; Julia Volaufova; Arlette Soros; William T Cefalu; Stuart Chalew; Stewart Gordon; Steven R Smith; Bradley R Newcomer; Michael Goran; Melinda Sothern Journal: Obesity (Silver Spring) Date: 2011-08-25 Impact factor: 5.002
Authors: Robert H Eckel; Steven E Kahn; Ele Ferrannini; Allison B Goldfine; David M Nathan; Michael W Schwartz; Robert J Smith; Steven R Smith Journal: J Clin Endocrinol Metab Date: 2011-06 Impact factor: 5.958
Authors: David E Brumbaugh; Tessa L Crume; Kristen Nadeau; Ann Scherzinger; Dana Dabelea Journal: J Clin Endocrinol Metab Date: 2012-04-16 Impact factor: 5.958
Authors: J Zabaleta; C Velasco-Gonzalez; J Estrada; E Ravussin; N Pelligrino; M C Mohler; E Larson-Meyer; A H Boulares; Y Powell-Young; B Bennett; K Happel; W Cefalu; R Scribner; T-S Tseng; M Sothern Journal: Int J Obes (Lond) Date: 2013-11-26 Impact factor: 5.095
Authors: Yi Ying Ong; Jonathan Y Huang; Navin Michael; Suresh Anand Sadananthan; Wen Lun Yuan; Ling-Wei Chen; Neerja Karnani; S Sendhil Velan; Marielle V Fortier; Kok Hian Tan; Peter D Gluckman; Fabian Yap; Yap-Seng Chong; Keith M Godfrey; Mary F-F Chong; Shiao-Yng Chan; Yung Seng Lee; Mya-Thway Tint; Johan G Eriksson Journal: J Clin Endocrinol Metab Date: 2021-04-23 Impact factor: 5.958
Authors: Rainer Lehmann; Holger Franken; Sascha Dammeier; Lars Rosenbaum; Konstantinos Kantartzis; Andreas Peter; Andreas Zell; Patrick Adam; Jia Li; Guowang Xu; Alfred Königsrainer; Jürgen Machann; Fritz Schick; Martin Hrabé de Angelis; Matthias Schwab; Harald Staiger; Erwin Schleicher; Amalia Gastaldelli; Andreas Fritsche; Hans-Ulrich Häring; Norbert Stefan Journal: Diabetes Care Date: 2013-03-20 Impact factor: 19.112